0.14
+0(+0.00%)
Currency In USD
| Previous Close | 0.14 |
| Open | 0.17 |
| Day High | 0.17 |
| Day Low | 0.14 |
| 52-Week High | 4.44 |
| 52-Week Low | 0.03 |
| Volume | 4.28M |
| Average Volume | 9.59M |
| Market Cap | 7.9M |
| PE | -0.11 |
| EPS | -1.32 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 1.21 |
| Change | 0 |
If you invested $1000 in Omega Therapeutics, Inc. (OMGA) since IPO date, it would be worth $8.91 as of August 18, 2025 at a share price of $0.143. Whereas If you bought $1000 worth of Omega Therapeutics, Inc. (OMGA) shares 3 years ago, it would be worth $29.16 as of August 18, 2025 at a share price of $0.143.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
GlobeNewswire Inc.
Oct 15, 2024 12:00 PM GMT
CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it wi
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
GlobeNewswire Inc.
Sep 17, 2024 11:00 AM GMT
Treatment with OTX-2002 led to controlled downregulation of MYC gene expression and resulted in significant inhibition of tumor growth as a monotherapy and in combination with standard of care agents in preclinical models of HCCProof-of-concept data